跳至主要内容
临床试验/IRCT20150713023190N13
IRCT20150713023190N13尚未招募2 期

Investigating the effect of oral supplement of achillea millefolium on HbA1C and peripheral neuropathy in type 2 diabetic patients

Rafsanjan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 no limit(—)
性别
All

入选标准

  • Having type II diabetes
  • Age over 40 years old
  • Inform consent for participate in the study
  • Getting a score above 7 from the Michigan neuropathy questionnaire
  • History of diabetes for at least five years

排除标准

  • Participate in another research project
  • Having other physical illnesses in addition to diabetes
  • Having psychiatric diseases
  • History of hereditary neuropathies or underlying diseases that cause neuropathy such as chronic uremia
  • Autoimmune diseases (rheumatism, multiple sclerosis, osteoarthritis)
  • Allergy to medicinal plants
  • Wounds or infections on the feet
  • Lower extremity amputation
  • Use of anticoagulant drugs

研究者

相似试验